OFFICIAL PUBLICATION OF

by its subsidiary APPco

The impact of COVID-19 on pharmacy legislation and innovative changes

Guest Author 14/02/2023

Disasters such as the Covid pandemic often result in innovation... but how did it pertain to pharmacy legislation? These researchers take a look... This article is the second in a series of articles about the impact of the COVID-19 pandemic on various aspects of pharmacy practice. Maria B Cooper1, Sara McMillan2,3, Elizabeth Hotham1, Kay Dunkley4,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

The impact of COVID-19 on pharmacy legislation and innovative changes

Previous Research Roundup

Next Gender pay-gap reopens for interns

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Research Roundup

Next Gender pay-gap reopens for interns

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.